| Released | Contributor | Author | Title | Pages | Price |
| 28-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 28-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for CBLI | 13 |
$25 |
| 26-Dec-2009 | PriceTarget Research, Inc. |
N/A
| Drug Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. | 65 |
$20 |
| 25-Dec-2009 | Pechala's Reports | Frantisek Pechala | CLEVELAND BIOLABS INC (CBLI=US) 12-months forecast | 1 |
$15 |
| 24-Dec-2009 | Pechala's Reports | Lubomir Pechala | CLEVELAND BIOLABS INC (CBLI=US) 2-weeks forecast | 1 |
$10 |
| 23-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: CLEVELAND BIOLAB -- CBLI | 1 |
$4 |
| 23-Dec-2009 | Jefferson Research |
N/A
| Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of CLEVELAND BIOLABS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 |
$20 |
| 23-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ANCI , CBLI , PMD , RGDX , TRCR -- MEDICAL SERVICES | 3 |
$4 |
| 21-Dec-2009 | Market Edge |
N/A
| Market Edge Equity Research Report | 4 |
$10 |
| 19-Dec-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for Cleveland Biolabs, Inc. | 40 |
$65 |
0.02% Nasdaq 
Research Reports
